CONGRESS ASSET MANAGEMENT CO /MA – Supernus Pharmaceuticals, Inc. Transaction History
CONGRESS ASSET MANAGEMENT CO /MA portfolio value:
$17.17M
portfolio value
CONGRESS ASSET MANAGEMENT CO /MA quarter portfolio value change:
+17.05%
quarter
Supernus Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +5.38% | 25.92K shares | 3.25M | $33.85 | 507.46K |
| Q2 2022 | share | Increase | +3.76% | 17.44K shares | -1.07M | $28.92 | 481.54K |
| Q1 2022 | share | Increase | +17.17% | 67.99K shares | 3.45M | $32.32 | 464.10K |
| Q4 2021 | share | Increase | +26.21% | 82.25K shares | 3.17M | $30.03 | 396.10K |
| Q3 2021 | share | Increase | +6.47% | 19.07K shares | -705K | $26.67 | 313.85K |
| Q2 2021 | share | Increase | 0.00% | 294.78K shares | 9.07M | $30.79 | 294.78K |